US$ 22.77
weight loss med tirzepatide | GLP1 | Medical What to Expect from Tirzepatide
Description
Medicare and Medicaid : Availability depends on the specific plan and state-level decisions, but coverage is possible with prior authorization

The Trump administration announced in April 2025 that Medicare would not cover GLP-1 drugs for weight loss, reversing a Biden-era decision

But insurance companies are not required to follow FDA labeling for coverage decisions

In reality, these are unapproved knockoffs that have not been approved as safe and effective and are often made with illicit foreign active pharmaceutical ingredients (API)

J Clin Med 2024
